Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type I Alpha-Interferon Receptor (IFNAR)
- Target
- IFNAR
- Molecular classification
- Receptor, Cytokine Receptor, Type I Cytokine Receptor
01
Overview
The type I alpha-interferon receptor (IFNAR) is a heterodimeric cell surface receptor complex that mediates the biological effects of all type I interferons (IFNs), including IFN-α and IFN-β. It consists of IFNAR1 and IFNAR2 subunits. Ligand binding activates the JAK/STAT signaling pathway, leading to antiviral, antiproliferative, and immunomodulatory responses.
- Other names
- Type I interferon receptor
02
Mechanism of action
Type I interferons bind to IFNAR, activating the JAK/STAT signaling pathway, leading to the transcription of interferon-stimulated genes (ISGs).
03
Biological functions
Signal transductionImmune responseAntiviral defenseCell proliferation inhibition
04
Disease associations
InfectionCancerAutoimmune diseasesInflammation
05
Safety considerations
AutoimmunityTissue damage due to chronic activationCytokine release syndrome
06
Interacting drugs
Type I Interferons (IFN-α, IFN-β, IFN-ε, IFN-κ, IFN-ω)
07
Biomarkers
Expression levels of ISGsIFNAR expression levelsSTAT phosphorylation
Beyond the preview
Go deeper on Type I Alpha-Interferon Receptor (IFNAR).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Type I Alpha-Interferon Receptor (IFNAR).